Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Articles

Researchers from Cellectis investigate how external signals in the tumor microenvironment could control the cell-surface expression and specificity of engineered CARs.

Cellectis Describes Novel CAR-T Design in New Paper

Merck will pay a one-time fee of $625 million and additional royalties to BMS and Ono Pharmaceutical to settle the patent infringement case related to Keytruda.

Merck Settles Litigation with Bristol-Myers Squibb on Use of Antibody Targeting PD-1

Camfil Air Pollution Control has expanded its testing laboratory and added a dust collection test rig for the ANSI dust collection standard.

Camfil APC Expands Laboratory for Testing Dust Collection Systems

EAG Laboratories offers dermal absorption studies using OECD methods.

EAG Laboratories Adds Capabilities in Dermal Absorption Testing

Researchers were not able to replicate all of the findings in five highly-cited cancer biology papers.

Reproducibility Project only Partially Able to Validate Findings of Prominent Cancer Studies

In a blog post, Robert Califf and Rita Nalubola discuss the agency’s approach to the use of genome-edited products.

FDA Describes Its Approach to Genome-Edited Products

FDA released a long-awaited draft guidance to help sponsors seeking to demonstrate interchangeability for biosimilar products.

Switching Studies Crucial to Demonstrate Biosimilar Interchangeability

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

An FDA guidance on biosimilar naming garnered mixed responses from the Biosimilars Forum, the American College of Rheumatology, and Pfenex.

FDA Guidance on Biosimilar Naming Receives Mixed Response from Industry

The membrane-based Protein A purification tool was unveiled at the 2017 PepTalk Conference in San Diego, California.

Gore Releases New Fluoropolymer-Based mAb Purification Technology

Language surrounding regenerative medicine and the REGROW Act appeared back into the 21st Century Cures Act right before it passed. What will this mean for the controversial testing and marketing of stem-cell therapies?